Please visit answersincme.com/NYN860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in neurology discusses the clinical significance and evidence for tumor-treating fields in patients with newly diagnosed glioblastoma. Upon completion of this activity, participants should be better able to: Explain the clinical role of tumor-treating fields (TTFields) as a component of a multimodal adjuvant strategy for the management of patients with newly diagnosed glioblastoma multiforme (nGBM); Review the clinical profiles of guideline-recommended adjuvant therapies for patients with nGBM; and Identify strategies to optimize the development of a multimodal adjuvant treatment plan for patients with nGBM.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related